These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1959990)

  • 1. Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Rosenblatt KA; Thomas DB
    Int J Cancer; 1991 Dec; 49(6):870-4. PubMed ID: 1959990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
    Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
    Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA).
    Voigt LF; Deng Q; Weiss NS
    Cancer Causes Control; 1994 May; 5(3):227-33. PubMed ID: 8061170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of low-dose oral contraceptives and stroke in young women.
    Schwartz SM; Siscovick DS; Longstreth WT; Psaty BM; Beverly RK; Raghunathan TE; Lin D; Koepsell TD
    Ann Intern Med; 1997 Oct; 127(8 Pt 1):596-603. PubMed ID: 9341057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraceptives and endometrial and ovarian carcinomas].
    Medl M
    Gynakol Geburtshilfliche Rundsch; 1998; 38(2):105-8. PubMed ID: 9815528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer and specific types of combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Thomas DB; Noonan EA
    Br J Cancer; 1992 Jan; 65(1):108-13. PubMed ID: 1733433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
    BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):498-505. PubMed ID: 8757151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: A retrospective cohort study of Danish women.
    Iversen L; Fielding S; Lidegaard Ø; Hannaford PC
    Contraception; 2020 Sep; 102(3):152-158. PubMed ID: 32592798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
    Brinton LA; Hoover RN
    Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Rosenblatt KA; Thomas DB; Noonan EA
    Eur J Cancer; 1992; 28A(11):1872-6. PubMed ID: 1389530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of oral contraceptives and endometrial cancer risk (Sweden).
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Lindgren A; Persson I
    Cancer Causes Control; 1999 Aug; 10(4):277-84. PubMed ID: 10482486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and endometrial cancer: do other risk factors modify the association?
    Stanford JL; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Hoover RN
    Int J Cancer; 1993 May; 54(2):243-8. PubMed ID: 8486426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.